Stay updated with Dei BioPharma’s latest breakthroughs, milestones, and industry insights in pharmaceutical innovation.
The U.S. Food and Drug Administration (FDA) has accepted an application from Uganda’s Dei BioPharma for the review of its...
UGANDA—Dr. Matthias Magoola, the founder and Managing Director of Dei Biopharma Ltd, has been honoured as a distinguished recipient of...
Abstract: MicroRNAs (miRNAs) maintain cellular homeostasis by blocking mRNAs by binding with them to fine-tune the expression of genes across...
Dr. Matthias Magoola Recognized at International Molecular Biologist Awards for Vaccine Research KAMPALA – Recognition for Groundbreaking Work in mRNA...
Job Application Instructions – Dei BioPharma Ltd How to Apply:Applications should be sent via email to recruitment@deibiopharma.com with the JOB...
MPs Urge Dei Biopharma to Accelerate Production of Life-Saving Medicines KAMPALA, September 29, 2024 – Members of Parliament on the...
Opposition Leader Joel Ssenyonyi Visits Dei BioPharma Facility in Matugga MATUGGA, September 19, 2024 – The sun shone brightly over...
KAMPALA – Dei BioPharma Wins Best Pharma Company at African Excellence Awards Dei BioPharma, Uganda’s first research-based biotechnology and pharmaceuticals...
The National Drug Authority (NDA) has granted Dei Biopharma Limited a landmark license to manufacture drugs at its Matugga premises....